Lansdowne Partners UK LLP boosted its stake in shares of Moderna, Inc. ( NASDAQ:MRNA – Get Rating ) by 25.2% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 36,000 shares of the company's stock after purchasing an additional 7,250 shares during the period. Moderna makes up approximately 1.3% of Lansdowne Partners UK LLP's portfolio, making the stock its 8th biggest holding. Lansdowne Partners UK LLP's holdings in Moderna were worth $6,466,000 as of its most recent filing with the SEC.

https://www.dailypolitical.com/2023/05/24/lansdowne-partners-uk-llp-buys-7250-shares-of-moderna-inc-nasdaqmrna.html

#dailypolitical